BPA for orentiram, remodulin, tyvaso, and unituxin

Ended Awarded Last action

Contract number
36E79720A0008
Awardee
Awarding agency
Task orders
6 $783,055 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$783,055 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 2% used
$50,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The U.S. Department of Veterans Affairs (VA) has awarded a $50 million Blanket Purchase Agreement (BPA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The BPA allows the VA to efficiently procure United Therapeutics' specialized drug portfolio, including Tyvaso, Remodulin, Orenitram, and Unituxin, which are used to treat pulmonary arterial hypertension and certain types of cancer. United Therapeutics also holds a $198 million Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs, further facilitating the VA's centralized sourcing of the company's entire medication lineup. Under these Indefinite Delivery Vehicles (IDVs), the VA has issued multiple firm-fixed-price delivery orders ranging from $13,050 to $366,330 for the supply of United Therapeutics' drugs to medical facilities across over 20 states. The contract awards do not have any set-aside designations, as these are commercial item procurements. The IDVs have periods of performance through 2025, allowing the VA to maintain a reliable supply of these critical pharmaceutical treatments for veterans nationwide.

Task orders

Task order Ordering agency Obligated Awarded
Tyvaso medication 36C24122N0162 Veterans Integrated Service Network 1 (VHA) $366,330
6 month order of tyvaso 0.6MG/ML refill kit 36C26322N0207 Veterans Integrated Service Network 23 (VHA) $75,656
Tyvaso 0.6MG/ML refill kit 36C26321N0978 Veterans Integrated Service Network 23 (VHA) $127,989
Tyvaso 36C24121N0566 Veterans Integrated Service Network 1 (VHA) $13,050
Tyvaso starter kit 36C24121F0109 Veterans Integrated Service Network 1 (VHA) $13,050
Medication tyvaso refill kit 36C24121N0238 Veterans Integrated Service Network 1 (VHA) $186,979

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00015 · 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00014 · This modification is issued to incorporate the product addition of 4 ndcs to BPA 36E79720A0008. $0
Exercise an Option P00013 · This modification is issued to exercise option year 4 for BPA 36E79720A0008. $0
Supplemental Agreement for work within scope P00012 · This modification is issued to incorporate a price change. $0
Supplemental Agreement for work within scope P00011 · 2024 public law updates $0
Supplemental Agreement for work within scope P00010 · This modification is issued to incorporate a price change for 7 orenitram ndcs on BPA 36E79720A0008. $0
Supplemental Agreement for work within scope P00009 · Product addition of 8 orenitram ndcs $0
Exercise an Option P00008 · Exercise option year 3 on BPA 36E79720A0008. $0
Supplemental Agreement for work within scope P00007 · 2023 public law pricing updates $0
Supplemental Agreement for work within scope P00006 · Product add (TYVASSO) $0
Exercise an Option P00005 · Exercise option year 2 on BPA #36E79720A0008 $0
Supplemental Agreement for work within scope P00004 · 2022 public law pricing updates $0
Exercise an Option P00003 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00002 · 2021 public law pricing update $0
Supplemental Agreement for work within scope P00001 · Price increase $0
Original award $0
Show all 16

Quick answers

Who was awarded contract 36E79720A0008?

36E79720A0008 was awarded to United Therapeutics Corp by National Acquisition Center (Headquarters) on April 24, 2020.

How much is contract 36E79720A0008 worth?

Orders under 36E79720A0008 have obligated $783,055. 36E79720A0008's own ceiling is $50,000,000.

How many orders have been placed under contract 36E79720A0008?

6 orders have been placed under 36E79720A0008, the latest on December 7, 2021.

Who can order from contract 36E79720A0008?

36E79720A0008 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79720A0008 under another contract?

Yes. 36E79720A0008 is a blanket purchase agreement under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79720A0008 competed?

The extent of competition for 36E79720A0008 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV